Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All genders, races, ethnicities
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30-days from the emergency department visit with suspicion of acs (acute coronary syndrome)
Awards & highlights
Study Summary
This protocol will collect real world EHR data to support the product development life cycle activities associated with developing the Major Adverse Cardiac Events (MACE) Clinical Decision Support (CDS) software. The data will also be utilized in subsequent clinical validation to support an FDA application and/or applications to other regulatory agencies as needed.
Eligible Conditions
- Cardiovascular Events
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 30-days from the emergency department visit with suspicion of acs (acute coronary syndrome)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30-days from the emergency department visit with suspicion of acs (acute coronary syndrome)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Performance Characteristics NPV (Negative Predictive Value), Specificity and Sensitivity
Trial Design
1Treatment groups
Experimental Treatment
Group I: Index EventExperimental Treatment1 Intervention
Patients with at least one Beckman High Sensitivity Troponin test at the Emergency Department visit
Find a Location
Who is running the clinical trial?
Beckman Coulter, Inc.Lead Sponsor
33 Previous Clinical Trials
434,736 Total Patients Enrolled
Alicia DrainStudy DirectorBeckman Coulter
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger